Abacus Life (NASDAQ:ABL) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
Abacus Life (NASDAQ:ABL) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
Abacus Life (NASDAQ:ABL) had its price target raised by analysts at Piper Sandler from $9.00 to $11.00. They now have an "overweight" rating on the stock.
Abacus Global Management Announces Transfer of Listing of its [Class A] Common Stock to the New York Stock Exchange with New Ticker Symbol “ABX”
Abacus Global Management Announces Upcoming Conference Participation